Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

A top-of-mind question for many clinical trial workers is whether AI could lead to job loss. After all, Goldman Sachs recently estimated that 300 million jobs could be lost or degraded due to AI ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO 35,048 people played the daily Crossword recently. Can you solve it faster than ...

Google has unveiled that healthcare provider Mayo Clinic will be the first to trial its Enterprise Search feature for building customized AI chatbots The search engine giant has made a string of ...

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

Ryan Han, Julián N Acosta, Zahra Shakeri,et al. Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review, The Lancet Digital Health (2024), DOI - 10. ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report. Jan. 21, 2025 9:39 AM ET Alphabet Inc. (GOOG) Stock, GOOGL Stock By: Ravikash Bakolia, SA News Editor 2 Comments.